News

Stocktwits on MSN9h
Summit Therapeutics Stock Slumps After Partner Akeso Gets FDA Nod For Cancer Drug: Retail’s Optimistic
Summit Therapeutics stock tumbled 37% on Friday afternoon after the U.S. Food and Drug Administration (FDA) approved its ...
Exclusive: US pharma tariffs would raise US drug costs by $51 billion annually, report finds
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...